Specific binding of [11C]raclopride and N-[3H]propyl-norapomorphine to dopamine receptors in living mouse striatum: Occupancy by endogenous dopamine and guanosine triphosphate-free G protein

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 5, 2002, Pages 596-604

  Cumming, Paul ^a   Wong, Dean F ^a   Gillings, Nicholas ^a   Hilton, John ^a   Scheffel, Ursula ^a   Gjedde, Albert ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Affinity; Agonist; Amphetamine; D2; Dopamine; N 3H propylnorapomorphine; Receptors; Reserpine; 11C raclopride

Indexed keywords

AMPHETAMINE; BENZAMIDE DERIVATIVE; CARBON 11; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; METIROSINE; PROPYLNORAPOMORPHINE; RACLOPRIDE; RADIOLIGAND; RESERPINE; SODIUM CHLORIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; MALE; MICHAELIS CONSTANT; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SYNAPTIC MEMBRANE;

EID: 0036254793     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200205000-00011     Document Type: Article

References (48)

1. From the cover: Increased basal occupancy of D2 receptors by dopamine in schizophrenia
2. The benzazepine, SCH 23390 inhibits 3H-NPA binding in mouse brain in vivo
3. 3H]spiperone binding in brain indicate two states of the D2-dopamine receptor
4. 3H]N-n-propylnorapomorphine
5. Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins
6. Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA
7. Selective antidopaminergic effects of S(+)N-m-propylnorapomorphines in limbic versus extrapyramidal sites in rat brain: Comparisons with typical and atypical antipsychotic agents
8. 3H]N,n-propylnorapomorphine
9. 11C]raclopride binding with continuous infusion
10. Dopamine D2 receptors in the rat brain: Autoradiographic visualization using a high affinity selective agonist ligand
11. 3H]CV 205-502
12. Radioligand binding studies: Evidence for multiple dopamine receptors
13. Interaction at the endplate receptors between different choline derivatives
14. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor
15. 11C-raclopride is altered by drugs that modify synaptic dopamine levels
16. 11C]-labeled raclopride, a specific dopamine-D2 receptor ligand
17. 11C]propylnorapomorphine
18. 11C]raclopride binding to D2-dopamine receptors in the monkey brain
19. Modeling neuroreceptor binding of radioligands in vivo
20. Quantification of neuroreceptors in living human brain. Part V: Endogenous neurotransmitter inhibition of haloperidol binding in psychosis
21. Transient analysis of irreversible and reversible tracer binding in human brain in vivo
22. 3H]N,n-propylnorapomorphine
23. Receptor recruitment: A mechanism for interactions between G protein-coupled receptors
24. (-)-N-[(11)C]propylnorapomorphine: A positron-labeled dopamine agonist for PET imaging of D(2) receptors
25. 3H]raclopride in reserpine-treated mouse brain
26. Most central nervous system D2 dopamine receptors are coupled to their effectors by Go
27. D2-family receptor distribution in human post mortem tissue: An autoradiographic study
28. 11]C]raclopride studies
29. Microdialysis and SPECT measurement of amphetamine-induced dopamine release in non-human primates
30. The dopamine D3 receptor: Neurobiology and potential clinical relevance
31. Die kinetik der invertinwirkung
32. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-proplyamino)tetralin in rodents and nonhuman primate
33. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning
34. 3H](+)PHNO
35. 3H-(-)-N-n-propylapomorphine in mouse brain
36. 3H-raclopride in the mouse brain in vivo
37. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model
38. 11C]raclopride at dopamine receptors in human brain
39. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: Differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors
40. Sensitization of G protein-coupled benzodiazepine receptors in the striatum of 6-hydroxydopamine-lesioned rats
41. In vivo binding of N,n-propylnorapomorphine in the rat brain: Regional localization, quantification in striatum and lack of correlation with dopamine metabolism
42. Tracer and maximal specific binding of tritiated spiperone and N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo
43. Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons
44. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors
45. Quantification of neuroreceptors in the living human brain. Part 1: Irreversible binding of ligands
46. 3H]raclopride binding in the rat brain
47. GABA(B) receptors: Altered coupling to G proteins in rats sensitized to amphetamine
48. 11C]methyl)norapomorphine